These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

229 related articles for article (PubMed ID: 19752199)

  • 1. Influence of the stereoisomeric position of the reactive acetate groups of the benzo[b]acronycine derivative S23906-1 on its DNA alkylation, helix-opening, cytotoxic, and antitumor activities.
    Depauw S; Gaslonde T; Léonce S; Kraus-Berthier L; Laine W; Lenglet G; Chiaroni A; Pfeiffer B; Bailly C; Michel S; Tillequin F; Pierré A; David-Cordonnier MH
    Mol Pharmacol; 2009 Dec; 76(6):1172-85. PubMed ID: 19752199
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Structure-activity relationships and mechanism of action of antitumor benzo[b]pyrano[3,2-h]acridin-7-one acronycine analogues.
    Thi Mai HD; Gaslonde T; Michel S; Tillequin F; Koch M; Bongui JB; Elomri A; Seguin E; Pfeiffer B; Renard P; David-Cordonnier MH; Laine W; Bailly C; Kraus-Berthier L; Léonce S; Hickman JA; Pierré A
    J Med Chem; 2003 Jul; 46(14):3072-82. PubMed ID: 12825945
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Synthesis, cytotoxic activity, and DNA binding properties of antitumor cis-1,2-dihydroxy-1,2-dihydrobenzo[b]acronycine cinnamoyl esters.
    Do Q; Tian W; Yougnia R; Gaslonde T; Pfeiffer B; Pierré A; Léonce S; Kraus-Berthier L; David-Cordonnier MH; Depauw S; Lansiaux A; Mazinghien R; Koch M; Tillequin F; Michel S; Dufat H
    Bioorg Med Chem; 2009 Mar; 17(5):1918-27. PubMed ID: 19217791
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Benzo[b]acronycine derivatives: a novel class of antitumor agents.
    Michel S; Gaslonde T; Tillequin F
    Eur J Med Chem; 2004 Aug; 39(8):649-55. PubMed ID: 15276298
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Synthesis, antitumor activity, and mechanism of action of benzo[a]pyrano[3,2-h]acridin-7-one analogues of acronycine.
    Nguyen TM; Sittisombut C; Boutefnouchet S; Lallemand MC; Michel S; Koch M; Tillequin F; Mazinghien R; Lansiaux A; David-Cordonnier MH; Pfeiffer B; Kraus-Berthier L; Léonce S; Pierré A
    J Med Chem; 2006 Jun; 49(11):3383-94. PubMed ID: 16722658
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Structure-activity relationships in the acronycine and benzo[b]acronycine series: role of the pyran ring.
    Do Q; Thi Mai HD; Gaslonde T; Pfeiffer B; Léonce S; Pierré A; Michel S; Tillequin F; Dufat H
    Eur J Med Chem; 2008 Dec; 43(12):2677-87. PubMed ID: 18342404
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Design of novel antitumor DNA alkylating agents: the benzacronycine series.
    David-Cordonnier MH; Laine W; Gaslonde T; Michel S; Tillequin F; Koch M; Léonce S; Pierré A; Bailly C
    Curr Med Chem Anticancer Agents; 2004 Mar; 4(2):83-92. PubMed ID: 15032716
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Design, synthesis, and cytotoxic activity of Michael acceptors and enol esters in the benzo[b]acronycine series.
    Doan Thi Mai H; Gaslonde T; Michel S; Koch M; Tillequin F; Bailly C; David-Cordonnier MH; Pfeiffer B; Léonce S; Pierré A
    Chem Pharm Bull (Tokyo); 2005 Aug; 53(8):919-22. PubMed ID: 16079520
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Synthesis, cytotoxic activity, and mechanism of action of furo[2,3-c]acridin-6-one and benzo[b]furo[3,2-h]acridin-6-one analogues of psorospermin and acronycine.
    Boutefnouchet S; Gaboriaud-Kolar N; Nguyen TM; Depauw S; David-Cordonnier MH; Pfeiffer B; Léonce S; Pierré A; Tillequin F; Lallemand MC; Michel S
    J Med Chem; 2008 Nov; 51(22):7287-97. PubMed ID: 18947222
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Covalent binding to glutathione of the DNA-alkylating antitumor agent, S23906-1.
    David-Cordonnier MH; Laine W; Joubert A; Tardy C; Goossens JF; Kouach M; Briand G; Thi Mai HD; Michel S; Tillequin F; Koch M; Leonce S; Pierre A; Bailly C
    Eur J Biochem; 2003 Jul; 270(13):2848-59. PubMed ID: 12823555
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Acronycine derivatives: a promising series of anticancer agents.
    Nguyen QC; Nguyen TT; Yougnia R; Gaslonde T; Dufat H; Michel S; Tillequin F
    Anticancer Agents Med Chem; 2009 Sep; 9(7):804-15. PubMed ID: 19594412
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Protein recognition of the S23906-1-DNA adduct by nuclear proteins: direct involvement of glyceraldehyde-3-phosphate dehydrogenase (GAPDH).
    Lenglet G; Depauw S; Mendy D; David-Cordonnier MH
    Biochem J; 2013 May; 452(1):147-59. PubMed ID: 23409959
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Covalent binding of antitumor benzoacronycines to double-stranded DNA induces helix opening and the formation of single-stranded DNA: unique consequences of a novel DNA-bonding mechanism.
    David-Cordonnier MH; Laine W; Lansiaux A; Rosu F; Colson P; de Pauw E; Michel S; Tillequin F; Koch M; Hickman JA; Pierré A; Bailly C
    Mol Cancer Ther; 2005 Jan; 4(1):71-80. PubMed ID: 15657355
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Synthesis and cytotoxic activity of benzo[a]acronycine and benzo[b]acronycine substituted on the A ring.
    Gaslonde T; Covello F; Velazquez-Alonso L; Léonce S; Pierré A; Pfeiffer B; Michel S; Tillequin F
    Eur J Med Chem; 2011 May; 46(5):1861-73. PubMed ID: 21411193
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Synthesis and cytotoxic and antitumor activity of 1,2-dihydroxy-1,2-dihydrobenzo[b]acronycine diacid hemiesters and carbamates.
    Doan Thi Mai H; Gaslonde T; Michel S; Koch M; Tillequin F; Pfeiffer B; Renard P; Kraus-Berthier L; Léonce S; Pierré A
    Chem Pharm Bull (Tokyo); 2004 Mar; 52(3):293-7. PubMed ID: 14993749
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Alkylation of guanine in DNA by S23906-1, a novel potent antitumor compound derived from the plant alkaloid acronycine.
    David-Cordonnier MH; Laine W; Lansiaux A; Kouach M; Briand G; Pierré A; Hickman JA; Bailly C
    Biochemistry; 2002 Aug; 41(31):9911-20. PubMed ID: 12146956
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [From acronycine to benzo-[b]-acronycine derivatives: potent antitumor agents].
    Koch M
    Bull Acad Natl Med; 2007 Jan; 191(1):83-91; discussion 91-3. PubMed ID: 17645109
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Synthesis of 6-dialkylaminoalkylamino pyrano[2,3-c]acridones and benzo[b]pyrano[3,2-h]acridones: soluble acronycine analogues with increased cytotoxic activity.
    Costes N; Elomri A; Dufat H; Michel S; Seguin E; Koch M; Tillequin F; Pfeiffer B; Renard P; Léonce S; Pierré A
    Oncol Res; 2003; 13(4):191-7. PubMed ID: 12659419
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [New antitumor agents in the acronycine series].
    Tillequin F
    Ann Pharm Fr; 2002 Jul; 60(4):246-52. PubMed ID: 12378151
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Structure activity relationships and mechanism of action of antitumor benzo[b]acronycine antitumor agents].
    Seguin E; Tillequin F
    Ann Pharm Fr; 2005 Jan; 63(1):44-52. PubMed ID: 15803100
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.